Ashar Bhavesh
Insider CIK 1849740 · SWTX Chief Commercial Officer · TYRA Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2026-05-05 | 2026-05-07 | 50,295 | — | $0 | 50,295 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2026-05-05 | 2026-05-07 | 15,013 | — | $0 | 15,013 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2025-12-01 | 2025-12-01 | 300,000 | — | $0 | 300,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 70,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 75,000 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 50,615 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer deriv | 2025-07-01 | 2025-07-02 | 21,654 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | D To issuer | 2025-07-01 | 2025-07-02 | 62,053 | — | $0 | 0 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2025-02-20 | 2025-02-24 | 1,016 | $61.19 | $62.2K | 62,053 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2025-01-10 | 2025-01-14 | 50,615 | — | $0 | 50,615 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2025-01-10 | 2025-01-14 | 17,323 | — | $0 | 63,069 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-06 | 2025-01-07 | 2,284 | $38.86 | $88.8K | 45,746 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-05 | 2025-01-07 | 3,825 | $38.19 | $146.1K | 48,030 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2025-01-04 | 2025-01-07 | 4,475 | $38.19 | $170.9K | 51,855 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,824 | $47.62 | $86.9K | 56,330 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-02-05 | 2024-02-05 | 4,834 | $49.32 | $238.4K | 58,154 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-02-02 | 2024-02-05 | 378 | $46.00 | $17.4K | 63,076 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-02-02 | 2024-02-05 | 1,089 | $43.75 | $47.6K | 65,121 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-02-02 | 2024-02-05 | 1,667 | $44.31 | $73.9K | 63,454 | SEC↗ |
| SWTX SpringWorks Therapeutics, | S Sale | 2024-02-02 | 2024-02-05 | 88 | $46.37 | $4.1K | 62,988 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-01-08 | 2024-01-08 | 1,449 | $41.53 | $60.2K | 66,210 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2024-01-05 | 2024-01-08 | 2,507 | $37.96 | $95.2K | 67,659 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2024-01-04 | 2024-01-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2024-01-04 | 2024-01-08 | 26,445 | — | $0 | 70,166 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2023-04-03 | 2023-04-05 | 1,375 | $25.25 | $34.7K | 43,721 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2023-01-06 | 2023-01-09 | 1,665 | $27.52 | $45.8K | 45,096 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2023-01-05 | 2023-01-09 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2023-01-05 | 2023-01-09 | 22,663 | — | $0 | 46,761 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-10-11 | 2022-10-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | F Tax w/h | 2022-04-01 | 2022-10-13 | 1,464 | $56.90 | $83.3K | 24,098 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2022-01-06 | 2022-01-10 | 40,710 | — | $0 | 40,710 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2022-01-06 | 2022-01-10 | 13,062 | — | $0 | 25,562 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award deriv | 2021-04-01 | 2021-04-01 | 92,000 | — | $0 | 92,000 | SEC↗ |
| SWTX SpringWorks Therapeutics, | A Award | 2021-04-01 | 2021-04-01 | 12,500 | — | $0 | 12,500 | SEC↗ |